latest news releases from the newsroom
Animal Health International, Inc.
Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2008 Earnings
WESTLAKE, Texas, Nov. 6, 2007 (PRIME NEWSWIRE) -- Animal Health International, Inc. (Nasdaq:AHII) announced today that net sales increased 12.8%, or $18.7 million, to $164.4 million for the three months ended September 30, 2007, from $145.7 million for the same quarter last year. Acquisitions accounted for $11.3 million or 60% of the increase in sales. Net income increased 13.3% to $1.0 million or $0.04 per fully diluted share.
QLogic Announces Approval of New Stock Repurchase Program for $200 Million
ALISO VIEJO, Calif., Nov. 6, 2007 (PRIME NEWSWIRE) -- QLogic Corp. (Nasdaq:QLGC), a leader in networking for storage and high performance computing (HPC), today announced that its board of directors has authorized a new program to repurchase up to $200 million of the company's outstanding common stock over the next two years. This action taken by the company's board of directors at a regularly scheduled meeting follows the company's most recent $300 million stock repurchase program adopted in April 2007.
Aquila Announces Earnings Webcast On November 8
KANSAS CITY, Mo., Nov. 6, 2007 (PRIME NEWSWIRE) -- Aquila, Inc. (NYSE:ILA) will conduct a conference call and webcast on Thursday, Nov. 8 at 9:30 a.m. Eastern Time to discuss 2007 third quarter results. Aquila's financial results on a Form 10-Q will be made public and a webcast presentation will be posted on the company's website, www.aquila.com, earlier on that date.
Universal Detection Technology
Anti-Microbial Solution Aimed At Killing MRSA to be Supplied by Universal Detection Technology
LOS ANGELES, Nov. 6, 2007 (PRIME NEWSWIRE) -- Universal Detection Technology (http://www.udetection.com) (OTCBB:UDTT) (Frankfurt:P08.F), a developer and provider of early-warning monitoring technologies to protect people from bioterrorism and radiological weapons, announced today the addition of a new product line to its solutions. The new product is an anti-microbial solution designed to kill over 99.99% of microbes it comes in contact with including the deadly MRSA (Methicillin-Resistant Staphylococcus Aureus).